Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Cardiovascular4053 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A24233 | 23073869 | Intern Emerg Med | Ultrasonography (US) and non-invasive diagnostic methods for non-alcoholic fatty liver disease (NAFLD) and early vascular damage. Possible application in a population study on the metabolic syndrome (MS). | 2012 | Details |
| A24238 | 23087748 | Hepat Mon | Effects of metformin, pioglitazone, and silymarin treatment on non-alcoholic Fatty liver disease: a randomized controlled pilot study. | 2012 | Details |
| A24240 | 23085576 | Eur J Gastroenterol Hepatol | Evaluation of early atherosclerosis markers in patients with nonalcoholic fatty liver disease. | 2013 | Details |
| A24246 | 23078220 | Can J Physiol Pharmacol | Endurance exercise in a rat model of metabolic syndrome. | 2012 | Details |
| A24248 | 23077931 | Rev Med Chir Soc Med Nat Iasi | The central role of the non alcoholic fatty liver disease in metabolic syndrome. | 2012 | Details |
| A24263 | 23066121 | J Clin Endocrinol Metab | Increased fetuin-A concentrations in impaired glucose tolerance with or without nonalcoholic fatty liver disease, but not impaired fasting glucose. | 2012 | Details |
| A24284 | 23040432 | Can J Cardiol | Association between nonalcoholic fatty liver disease and cardiovascular risk in obese children and adolescents. | 2012 | Details |
| A24296 | 23028811 | PLoS One | Glucose intolerance and the amount of visceral adipose tissue contribute to an increase in circulating triglyceride concentrations in Caucasian obese females. | 2012 | Details |
| A24310 | 23018041 | Nutr Metab Cardiovasc Dis | Arterial function and structure after a 1-year lifestyle intervention in children with nonalcoholic fatty liver disease. | 2012 | Details |
| A24323 | 22999011 | Metabolism | In patients with non-alcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not. | 2012 | Details |
| A24347 | 22980050 | Best Pract Res Clin Endocrinol Metab | Glucocorticoids as mediators of developmental programming effects. | 2012 | Details |
| A24388 | 22949106 | Curr Atheroscler Rep | Fructose and risk of cardiometabolic disease. | 2012 | Details |
| A24389 | 22942630 | Int J Angiol | Carotid intima-media thickness and liver histology in hemodialysis patients with nonalcoholic Fatty liver disease. | 2011 | Details |
| A24392 | 22940679 | J Hypertens | High ambulatory blood pressure values associated with non-alcoholic fatty liver in middle-aged adults. | 2012 | Details |
| A24398 | 22935341 | Nutr Res | The lipid accumulation product is highly related to serum alanine aminotransferase level in male adults. | 2012 | Details |
| A24435 | 22899406 | Georgian Med News | [Peculiarities of metabolic syndrome and nonalcogolic fatty liver disease in menopausal women]. | 2012 | Details |
| A24445 | 22884916 | Atherosclerosis | Liver fat content is associated with increased carotid atherosclerosis in a Chinese middle-aged and elderly population: the Shanghai Changfeng study. | 2012 | Details |
| A24461 | 22875138 | Pediatr Cardiol | The relationship between pediatric nonalcoholic fatty liver disease and cardiovascular risk factors and increased risk of atherosclerosis in obese children. | 2012 | Details |
| A24467 | 22868011 | J Coll Physicians Surg Pak | Serum cholesterol: could it be a sixth parameter of Child-Pugh scoring system in cirrhotics due to viral hepatitis? | 2012 | Details |
| A24500 | 22829522 | Diabetes Care | Fatty liver, insulin resistance, and features of metabolic syndrome: relationships with coronary artery calcium in 10,153 people. | 2012 | Details |
| A24502 | 22827449 | Clin Sci (Lond) | Cardiovascular disease is associated with high-fat-diet-induced liver damage and up-regulation of the hepatic expression of hypoxia-inducible factor 1α in a rat model. | 2013 | Details |
| A24507 | 22824483 | Clin Liver Dis | The cardiovascular link to nonalcoholic fatty liver disease: a critical analysis. | 2012 | Details |
| A24516 | 22821716 | Liver Transpl | Reducing the load: the evolution and management of obesity and nonalcoholic steatohepatitis before liver transplantation. | 2012 | Details |
| A24522 | 22814750 | Arterioscler Thromb Vasc Biol | Nonalcoholic fatty liver disease is associated with atherosclerosis in middle-aged and elderly Chinese. | 2012 | Details |
| A24527 | 22807031 | Diabetes | Fat-specific DsbA-L overexpression promotes adiponectin multimerization and protects mice from diet-induced obesity and insulin resistance. | 2012 | Details |
| A24532 | 22796347 | Nutr Metab Cardiovasc Dis | Ambulatory arterial stiffness indices and non-alcoholic fatty liver disease in essential hypertension. | 2012 | Details |
| A24540 | 22788090 | Rom J Intern Med | Non-alcoholic fatty liver disease and the statins treatment. | 2012 | Details |
| A24543 | 22770622 | Expert Opin Pharmacother | The safety and effectiveness of statins as treatment for HIV-dyslipidemia: the evidence so far and the future challenges. | 2012 | Details |
| A24550 | 22764020 | Am J Gastroenterol | What should we recommend to our patients with NAFLD regarding alcohol use? | 2012 | Details |
| A24564 | 22746301 | Curr Drug Metab | Drug disposition in pathophysiological conditions. | 2012 | Details |
| A24568 | 22741595 | J Gastroenterol Hepatol | Prevalence and risk factors for non-alcoholic fatty liver disease in Asian people who are not obese. | 2012 | Details |
| A24574 | 22735606 | Eur J Gastroenterol Hepatol | The alanine aminotransferase to triglycerides ratio as a marker to identify nonalcoholic fatty liver disease. | 2012 | Details |
| A24580 | 22730617 | Rev Med Suisse | [Diabetes and non-alcoholic fatty liver disease]. | 2012 | Details |
| A24585 | 22722431 | Dig Dis | Nonalcoholic fatty liver disease/steatohepatitis: epidemiology, pathogenesis, clinical presentation and treatment. | 2012 | Details |
| A24587 | 22720278 | Can J Gastroenterol | Current treatment options for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. | 2012 | Details |
| A24588 | 22720061 | PLoS One | Inhibition of soluble epoxide hydrolase attenuates high-fat-diet-induced hepatic steatosis by reduced systemic inflammatory status in mice. | 2012 | Details |
| A24592 | 22717200 | J Acad Nutr Diet | The role of diet and nutrient composition in nonalcoholic Fatty liver disease. | 2012 | Details |
| A24612 | 22691891 | Minerva Endocrinol | Is NAFLD an independent risk factor for increased IMT in T2DM? | 2012 | Details |
| A24619 | 22684858 | Hepatology | Nonalcoholic steatohepatitis versus steatosis: adipose tissue insulin resistance and dysfunctional response to fat ingestion predict liver injury and altered glucose and lipoprotein metabolism. | 2012 | Details |
| A24626 | 22676641 | Clin Endocrinol (Oxf) | Plasma fetuin-A is associated with endothelial dysfunction and subclinical atherosclerosis in subjects with nonalcoholic fatty liver disease. | 2013 | Details |
| A24628 | 22674675 | Phytother Res | Chlorogenic acid exhibits cholesterol lowering and fatty liver attenuating properties by up-regulating the gene expression of PPAR-α in hypercholesterolemic rats induced with a high-cholesterol diet. | 2012 | Details |
| A24634 | 22672330 | Diabet Med | Dorothy Hodgkin Lecture 2012: non-alcoholic fatty liver disease, insulin resistance and ectopic fat: a new problem in diabetes management. | 2012 | Details |
| A24647 | 22652341 | Drug Discov Today | Farnesoid X receptor targeting to treat nonalcoholic steatohepatitis. | 2012 | Details |
| A24649 | 22651705 | Liver Int | Heritability of non-alcoholic fatty liver disease and association with abnormal vascular parameters: a twin study. | 2012 | Details |
| A24653 | 22646469 | Platelets | Mean platelet volume in biopsy-proven non-alcoholic fatty liver disease. | 2012 | Details |
| A24654 | 22646061 | Intern Med J | Awareness and opinions of non-alcoholic fatty liver disease by hospital specialists. | 2013 | Details |
| A24657 | 25755422 | J Clin Exp Hepatol | Epidemiology and Natural History of Non-alcoholic Fatty Liver Disease. | 2012 | Details |
| A24678 | 22615952 | PLoS One | A cohort study of serum bilirubin levels and incident non-alcoholic fatty liver disease in middle aged Korean workers. | 2012 | Details |
| A24684 | 22611040 | Hepatology | Patients transplanted for nonalcoholic steatohepatitis are at increased risk for postoperative cardiovascular events. | 2012 | Details |
| A24690 | 22596186 | Curr Opin Cardiol | Nonalcoholic fatty liver disease and vascular risk. | 2012 | Details |
| A24711 | 22570770 | J Nutr Metab | Health implications of high dietary omega-6 polyunsaturated Fatty acids. | 2012 | Details |
| A24719 | 22565095 | Nat Rev Gastroenterol Hepatol | Increased risk of cardiovascular disease and chronic kidney disease in NAFLD. | 2012 | Details |
| A24723 | 22560219 | Cell Metab | Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease. | 2012 | Details |
| A24747 | 22541252 | Gastroenterol Hepatol | [Influence of non-alcoholic fatty liver disease on cardiovascular disease]. | 2012 | Details |
| A24749 | 22539458 | Diabetes Metab Res Rev | Hepatic lipase activity is increased in non-alcoholic fatty liver disease beyond insulin resistance. | 2012 | Details |
| A24750 | 22538930 | Eur J Nutr | Ellagic acid attenuates high-carbohydrate, high-fat diet-induced metabolic syndrome in rats. | 2012 | Details |
| A24753 | 22535755 | J Nutr | Quercetin ameliorates cardiovascular, hepatic, and metabolic changes in diet-induced metabolic syndrome in rats. | 2012 | Details |
| A24759 | 22531091 | Int J Obes (Lond) | Effect of intrauterine growth retardation on liver and long-term metabolic risk. | 2012 | Details |
| A24767 | 22521357 | J Hepatol | Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD). | 2012 | Details |
| A24787 | 22495402 | Eur J Gastroenterol Hepatol | Relation of epicardial adipose tissue and carotid intima-media thickness in patients with nonalcoholic fatty liver disease. | 2012 | Details |
| A24789 | 22490991 | J Endocrinol Invest | Non-alcoholic fatty liver disease is independently associated with left ventricular hypertrophy in hypertensive Type 2 diabetic individuals. | 2012 | Details |
| A24798 | 22481454 | Ann Hepatol | High coffee intake is associated with lower grade nonalcoholic fatty liver disease: the role of peripheral antioxidant activity. | 2012 | Details |
| A24809 | 22469639 | J Clin Gastroenterol | Cardiovascular disease and nonalcoholic fatty liver disease: does histologic severity matter? | 2012 | Details |
| A24812 | 22364603 | Actas Dermosifiliogr | [Integrated approach to comorbidity in patients with psoriasis.Working Group on Psoriasis-associated Comorbidities]. | 2012 | Details |
| A24838 | 22441997 | Zentralbl Chir | [NASH (non-alcoholic steatohepatitis): fatty liver or fatal liver disease?]. | 2012 | Details |
| A24865 | 22419057 | Dig Dis Sci | Lipid-lowering agents in nonalcoholic fatty liver disease and steatohepatitis: human studies. | 2012 | Details |
| A24868 | 22418889 | Semin Liver Dis | Exercise and the liver: implications for therapy in fatty liver disorders. | 2012 | Details |
| A24869 | 22418888 | Semin Liver Dis | Obstructive sleep apnea-hypopnea syndrome and nonalcoholic fatty liver disease: emerging evidence and mechanisms. | 2012 | Details |
| A24870 | 22418887 | Semin Liver Dis | Hypercoagulation and thrombophilia in nonalcoholic fatty liver disease: mechanisms, human evidence, therapeutic implications, and preventive implications. | 2012 | Details |
| A24872 | 22418885 | Semin Liver Dis | Dyslipidemia in patients with nonalcoholic fatty liver disease. | 2012 | Details |
| A24873 | 22418884 | Semin Liver Dis | NAFLD in the absence of metabolic syndrome: different epidemiology, pathogenetic mechanisms, risk factors for disease progression? | 2012 | Details |
| A24879 | 22408036 | Eur Heart J | Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor? | 2012 | Details |
| A24883 | 22397032 | Adv Clin Chem | Fetuin-A and the cardiovascular system. | 2012 | Details |
| A24886 | 22395062 | J Clin Gastroenterol | Nonalcoholic fatty liver disease: multimodal treatment options for a pathogenetically multiple-hit disease. | 2012 | Details |
| A24889 | 22391060 | Proc Nutr Soc | Potential health benefits of moderate alcohol consumption: current perspectives in research. | 2012 | Details |
| A24892 | 22386931 | Metabolism | Serum ferritin levels predict incident non-alcoholic fatty liver disease in healthy Korean men. | 2012 | Details |
| A24895 | 22385608 | Kaohsiung J Med Sci | Severity of fatty liver on ultrasound correlates with metabolic and cardiovascular risk. | 2012 | Details |
| A24901 | 22378327 | J Nutr | Coffee extract attenuates changes in cardiovascular and hepatic structure and function without decreasing obesity in high-carbohydrate, high-fat diet-fed male rats. | 2012 | Details |
| A24918 | 22362903 | Postgrad Med J | Xanthelasma palpebrarum: a marker of premature atherosclerosis (risk of atherosclerosis in xanthelasma). | 2012 | Details |
| A24921 | 22359630 | PLoS One | Decreased circulating endothelial progenitor cell levels and function in patients with nonalcoholic fatty liver disease. | 2012 | Details |
| A24923 | 22356310 | J Dig Dis | Natural course of nonalcoholic fatty liver disease in southern China: a prospective cohort study. | 2012 | Details |
| A24942 | 22331365 | J Gastroenterol | Metabolic markers and ALT cutoff level for diagnosing nonalcoholic fatty liver disease: a community-based cross-sectional study. | 2012 | Details |
| A24951 | 22326434 | Gastroenterology | Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications. | 2012 | Details |
| A24964 | 22307032 | Gastroenterology | Hepatic cannabinoid receptor-1 mediates diet-induced insulin resistance via inhibition of insulin signaling and clearance in mice. | 2012 | Details |
| A24971 | 22294826 | World J Gastroenterol | Aging is a risk factor of nonalcoholic fatty liver disease in premenopausal women. | 2012 | Details |
| A24972 | 22294100 | Cell Mol Life Sci | A role for sphingolipids in the pathophysiology of obesity-induced inflammation. | 2012 | Details |
| A24973 | 22291824 | Arch Med Sci | Safety and impact on cardiovascular events of long-term multifactorial treatment in patients with metabolic syndrome and abnormal liver function tests: a post hoc analysis of the randomised ATTEMPT study. | 2011 | Details |
| A24982 | 22280920 | Physiol Behav | Non-alcoholic fatty liver disease impairs hippocampal-dependent memory in male rats. | 2012 | Details |
| A24984 | 22278337 | Diabetologia | Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials. | 2012 | Details |
| A24985 | 22278114 | Panminerva Med | A 2012 clinical update for internists in adult nonalcoholic fatty liver disease. | 2012 | Details |
| A25016 | 22245962 | Clin Gastroenterol Hepatol | Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US population. | 2012 | Details |
| A25020 | 22240370 | Clin Hemorheol Microcirc | Elevated hematocrit in nonalcoholic fatty liver disease: a potential cause for the increased risk of cardiovascular disease? | 2012 | Details |
| A25022 | 22239839 | Dan Med J | Low incidence of non-alcoholic steatohepatitis in a Danish liver unit. | 2012 | Details |
| A25023 | 22239625 | Curr Vasc Pharmacol | Non-alcoholic fatty liver disease in type 2 diabetes: pathogenesis and treatment options. | 2012 | Details |
| A25057 | 27326050 | Heart Asia | Non-alcoholic fatty liver disease and outcomes in persons with acute coronary syndromes: insights from the GRACE-ALT analysis. | 2012 | Details |
| A25066 | 23750438 | Przegl Lek | [Nonalcoholic fatty liver disease as a risk factor of macroangiopahty in patients with type 2 diabetes]. | 2012 | Details |
| A25070 | 22197629 | Dig Liver Dis | Silibinin improves hepatic and myocardial injury in mice with nonalcoholic steatohepatitis. | 2011 | Details |
| A25075 | 22189171 | Diabetes Res Clin Pract | Elevated asymmetric dimethylarginine in plasma: an early marker for endothelial dysfunction in non-alcoholic fatty liver disease? | 2011 | Details |
| A25078 | 22187656 | J Lipids | Non-alcoholic Fatty liver disease: the bile Acid-activated farnesoid x receptor as an emerging treatment target. | 2011 | Details |
| A25090 | 22181832 | Intern Med J | Relationship between non-alcoholic fatty liver disease and pulmonary function. | 2012 | Details |